Congressional leaders are working on a “compromise” of the so-called CREATES Act, a longtime priority for generic drug makers, Speaker Paul Ryan said Thursday.

The Wisconsin Republican mentioned the legislation in response to a question about what Congress could do to help lower drug prices, after President Trump gave a much-ballyhooed speech on that issue last week. Ryan didn’t give many specifics in his comments, which came at a Washington event hosted by the law firm BakerHostetler.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy